|
| | Cudratricusxanthone A Basic information |
| Product Name: | Cudratricusxanthone A | | Synonyms: | 2,3,6,8-Tetrahydroxy-5-(2-methyl-3-buten-2-yl)-1-(3-methyl-2-buten-1-yl)-9H-xanthen-9-one;Cudratricusxanthone A;2,3,6,8-tetrahydroxy-5-(2-methylbut-3-en-2-yl)-1-(3-methylbut-2-enyl)xanthen-9-one;9H-Xanthen-9-one, 5-(1,1-dimethyl-2-propen-1-yl)-2,3,6,8-tetrahydroxy-1-(3-methyl-2-buten-1-yl)-;2,3,6,8-Tetrahydroxy-1-(3-methylbut-2-en-1-yl)-5-(2-methylbut-3-en-2-yl)-9H-xanthen-9-one | | CAS: | 740810-42-8 | | MF: | C23H24O6 | | MW: | 396.43 | | EINECS: | | | Product Categories: | | | Mol File: | 740810-42-8.mol |  |
| | Cudratricusxanthone A Chemical Properties |
| Melting point | 145 °C(Solv: chloroform (67-66-3)) | | Boiling point | 626.3±55.0 °C(Predicted) | | density | 1.315±0.06 g/cm3(Predicted) | | pka | 6.73±0.20(Predicted) |
| | Cudratricusxanthone A Usage And Synthesis |
| Definition | ChEBI: Cudratricusxanthone A is a member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 2, 3, 6 and 8, an isoprenyl group at position 1 and a 2-methylbut-3-en-2-yl group at position 5. It is isolated from the root barks of Cudrania tricuspidata and exhibits cytotoxicity towards human cancer cell lines. It has a role as a metabolite, an antineoplastic agent, an EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor and an anti-inflammatory agent. It is a member of xanthones and a polyphenol. |
| | Cudratricusxanthone A Preparation Products And Raw materials |
|
